Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Vivos Therapeutics, Inc. (VVOS) had Operating Cash Flow per Share of $-0.80 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$3.82M |
|
$-5.01M |
|
$1.71M |
|
$2.11M |
|
$8.69M |
|
$-4.87M |
|
$-0.15M |
|
$-5.01M |
|
$-5.01M |
|
$-5.01M |
|
$-5.01M |
|
$-5.01M |
|
$-5.01M |
|
$-4.87M |
|
$-4.56M |
|
9.09M |
|
9.09M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$6.73M |
|
$5.13M |
|
$19.30M |
|
$26.03M |
|
$6.43M |
|
$7.76M |
|
$15.02M |
|
$21.45M |
|
$4.58M |
|
$-6.09M |
|
$4.58M |
|
7.32M |
|
| Cash Flow Statement Financials | |
$-7.29M |
|
$-6.03M |
|
$11.46M |
|
$6.26M |
|
$4.40M |
|
$-1.86M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.05 |
|
-- |
|
-- |
|
0.63 |
|
1.73 |
|
55.24% |
|
-127.36% |
|
-127.36% |
|
-- |
|
-131.23% |
|
-131.23% |
|
$-8.18M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
2.34 |
|
38.47 |
|
-109.38% |
|
82.29% |
|
-19.26% |
|
-40.61% |
|
$0.63 |
|
$-0.90 |
|
|
Operating Cash Flow per Share |
$-0.80 |